EcoDrugPlus

Ensembl ID : ENSNBRG00000016856
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSNBRG00000003276
Gene Symbol: -
Cross references: -
222 Possible Orthologues:

Ensembl ID : ENSNBRG00000002000
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSNBRG00000022189
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSNBRG00000002326
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSNBRG00000008388
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSNBRG00000017874
Gene Symbol: -
Cross references: -
269 Possible Orthologues:

Ensembl ID : ENSNBRG00000023900
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSNBRG00000023786
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSNBRG00000019282
Gene Symbol: -
Cross references: -
39 Possible Orthologues:

Ensembl ID : ENSNBRG00000023345
Gene Symbol: -
Cross references: -
167 Possible Orthologues:

Ensembl ID : ENSNBRG00000023338
Gene Symbol: -
Cross references: -
167 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).